1. Home
  2. NVCR vs PD Comparison

NVCR vs PD Comparison

Compare NVCR & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • PD
  • Stock Information
  • Founded
  • NVCR 2000
  • PD 2009
  • Country
  • NVCR Switzerland
  • PD United States
  • Employees
  • NVCR N/A
  • PD N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • PD Computer Software: Prepackaged Software
  • Sector
  • NVCR Health Care
  • PD Technology
  • Exchange
  • NVCR Nasdaq
  • PD Nasdaq
  • Market Cap
  • NVCR 1.9B
  • PD 1.4B
  • IPO Year
  • NVCR 2015
  • PD 2019
  • Fundamental
  • Price
  • NVCR $17.71
  • PD $15.99
  • Analyst Decision
  • NVCR Buy
  • PD Buy
  • Analyst Count
  • NVCR 6
  • PD 12
  • Target Price
  • NVCR $32.83
  • PD $19.50
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • PD 1.6M
  • Earning Date
  • NVCR 07-24-2025
  • PD 09-02-2025
  • Dividend Yield
  • NVCR N/A
  • PD N/A
  • EPS Growth
  • NVCR N/A
  • PD N/A
  • EPS
  • NVCR N/A
  • PD N/A
  • Revenue
  • NVCR $621,711,000.00
  • PD $476,132,000.00
  • Revenue This Year
  • NVCR $5.56
  • PD $9.60
  • Revenue Next Year
  • NVCR $9.19
  • PD $7.56
  • P/E Ratio
  • NVCR N/A
  • PD N/A
  • Revenue Growth
  • NVCR 18.27
  • PD 8.55
  • 52 Week Low
  • NVCR $14.17
  • PD $13.70
  • 52 Week High
  • NVCR $34.13
  • PD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 51.32
  • PD 59.65
  • Support Level
  • NVCR $17.53
  • PD $15.09
  • Resistance Level
  • NVCR $18.70
  • PD $16.49
  • Average True Range (ATR)
  • NVCR 0.72
  • PD 0.46
  • MACD
  • NVCR 0.09
  • PD 0.20
  • Stochastic Oscillator
  • NVCR 60.56
  • PD 94.64

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

Share on Social Networks: